Jci_page_head_homepage_01 Jci_page_head_homepage_02
Yoshiaki Kubota, Masanori Hirashima, Kazuo Kishi, Colin L. Stewart, Toshio Suda
Published in Volume 118, Issue 7
J Clin Invest. 2008; 118(7):2393–2403 doi:10.1172/JCI34882
Abstract | Full text | PDF | Supplemental material
Options: View larger image (or click on image)
Medium
Figure 3
Lif–/– mice show increased proliferation in endothelial cells and astrocytes.

(AL) Triple IHC for PECAM-1, PDGFRα, and pax-2. Note the densely condensed astrocyte network (asterisks) in the hypervascularized area (arrowheads) of Lif–/– mice at P0.5 and P4. (M and N) Transition of vascular density (M) or the number of astrocytes identified as pax-2+ nuclei in vascularized area (N). Data are means of 4–8 random FOV in the vascularized area per retina (n = 5). (O and P) BrdU incorporation assay combined with triple IHC for PECAM-1, PDGFRα, and DAPI in P4 retinas. Note the BrdU+ astrocytes (asterisks) and endothelial cells (black dots) in the Lif–/– retina. (Q) Quantification of BrdU+ astrocytes and endothelial cells. Data are means from 8 random FOV around the sprouting edge per retina (n = 7). (R and S) IHC for neurofilament on P4 retinas. (T) Quantitative PCR of pdgfa for isolated RNA from P4 retinas (n = 5). (U and V) Confocal images of FITC labeled with PECAM-1 in the retinas perfused with FITC-dextran. Dextran was perfused into the stalk cells (arrowheads) in both Lif+/+ and Lif–/– mice. (W and X) Triple IHC for PECAM-1, Mac-1, and desmin in P4 retinas. Scale bars: 50 μm. *P < 0.03 versus Lif+/+.